ANDHealth, an Australian organisation dedicated to supporting digital health companies in their commercialisation journey, recently announced the two-year commercial growth outcomes of its first 10 ANDHealth+ cohort companies at the Global HLTH Conference in Las Vegas, USA.
According to its official release, ANDHealth has onboarded 10 companies since 2017, raising A$24 million in new capital, creating 119 new jobs, generating A$7.5 million in new revenues and selling to 139 customers. Five hundred twenty-four commercial pilots and 23 clinical studies of these innovative products have now been undertaken across the world, and 44,895 patients/users have so far benefited from these disruptive Australian digital health technologies.
ANDHealth cohort companies include:
- CancerAid – an app that supports and provides education and information to cancer patients and families through a community platform, health coaching and clinician-connected care;
- Atmo BioSciences – an ingestible pill sensor that provides real-time gas information for gut health diagnosis and management;
- Seer Medical – hospital standard epilepsy monitoring and diagnosis delivered digitally in the home, including an app to keep track of seizures; and
- Vitalic Medical – a non-invasive monitoring system that detects early signs of patient deterioration and alerts staff to potential falls.
Following the success of the initial two-year pilot, ANDHealth is in late stage discussions with new industry members internationally and is looking to engage with key government agencies that recognise the critical need to support the nascent digital health sector in Australia.
THE LARGER TREND
In July this year, ANDHealth partnered with a consortium of leading medical research institutes and universities in Western Australia (WA), led by the Telethon Kids Institute, as part of the state’s first Digital Health Accelerator Program. Under the new partnership, ANDHealth will deliver its BRIGHT IDEATE and BRIGHT INNOVATE programs as part of the Digital Health Accelerator Program.
ON THE RECORD
“Our initial pilot funding from MTPConnect established ANDHealth as a unique industry-led intervention to support and turbocharge commercialisation of Australian technologies in the rapidly emerging digital health sector,” said Bronwyn Le Grice, ANDHealth founder and CEO, in a statement.
“We set out to disrupt the way commercialisation support and accelerator programs were delivered via a unique non-profit structure, and we are delighted with the success our cohort companies have achieved. These companies are actively exporting, manufacturing and creating high value jobs for Australians,” Le Grice said.